Lloyd Price

FEBRUARY 18, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. This could negatively impact companies specialising in these devices.

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Lloyd Price

NOVEMBER 21, 2023

By implementing these strategies, Palantir can effectively address public concerns, build trust, and gain acceptance for its role in delivering the NHS Federated Data Platform, ultimately contributing to improved patient care and healthcare outcomes in England. Palantir's plans for healthcare are ambitious. Buy, build or partner?

Drug Development 70

Drug Development Health science healthcare technology Leadership 70

Lloyd Price

FEBRUARY 18, 2024

They might target smaller, innovative companies with niche solutions or complementary technologies at reasonable valuations. Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making.

Pharmaceuticals 64

Pharmaceuticals healthcare technology Digital Health Remote care 64

Lloyd Price

MAY 2, 2024

Digital Biology: Tools like BioNeMo utilise AI to analyse vast amounts of biological data, leading to breakthroughs in drug development and understanding of diseases. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk

healthcare technology 73

healthcare technology Drug Development Leadership Digital Health 73

Lloyd Price

APRIL 22, 2024

Growing Market: The global market for AI in healthcare is projected to reach astronomical figures in the coming years, reflecting the confidence in this technology. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk

healthcare technology 60

healthcare technology Leadership Drug Development Digital Health 60

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88